US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

COYA THERAPEUTICS INC

6.57

+0.860015.06%

Volume:126.03K

Turnover:805.62K

Market Cap:109.88M

PE:-6.73

High:6.75

Open:5.83

Low:5.72

Close:5.71

Loading ...

Overview Company News Filings

Coya: Low-Dose IL-2 in AD patients resulted in reduced proinflammatory markers

Coya Therapeutics Inc - Ld Il-2 Well-Tolerated With No Serious Adverse Events Reported

THOMSON REUTERS

Coya Therapeutics Inc - Reports Significant Improvement in Inflammatory Markers in Alzheimer's Patients

THOMSON REUTERS

Coya Therapeutics Inc - Monthly Ld Il-2 Shows Significant Reduction in Ccl2 and Il-15, Increase in Il-4

THOMSON REUTERS

Coya Therapeutics Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer’s Disease Following Monthly Dosing with Low-Dose IL-2, Further Supporting Clinical Development

Coya Therapeutics Is Maintained at Buy by D. Boral Capital

Coya Therapeutics Announces Pipeline Expansion - Coya 303: Coya 301 in Combination With Glp-1 Receptor Agonist for the Treatment of Inflammatory Diseases

THOMSON REUTERS

EXCLUSIVE: Coya Therapeutics Expands Its Pipeline With Combo Therapy For Inflammatory Diseases

Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (Ld Il-2) + Ctla4-Ig Fusion Protein in Patients With Frontotemporal Dementia (Ftd)

THOMSON REUTERS

Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)

Coya Therapeutics initiated with a Buy at D. Boral Capital

Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference

Coya Therapeutics files to sell 1.38M shares of common stock for holders

BRIEF-Coya Therapeutics Inc Files For Resale Of Up To 1.4 Million Shares By The Selling Stockholders - SEC Filing

Coya Therapeutics Inc Files for Resale of up to 1.4 Mln Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS

Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders

Coya Therapeutics: Expects in Q1/Q2 2025 Coya 301/Glp-1 Combination Data Submission for Publication and Additional Intellectual Property Filings

THOMSON REUTERS

Press Release: Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results

Calendar of U.S. Earnings Expected in the Week Ahead

Coya Therapeutics New CEO Arun Swaminathan Takes Helm

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COYA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","market":"US","secType":"STK","nameCN":"COYA THERAPEUTICS INC","latestPrice":6.57,"timestamp":1745345056564,"preClose":5.71,"halted":0,"volume":126032,"delay":0,"floatShares":12564296,"shares":16724998,"eps":-0.976498,"marketStatus":"Trading","change":0.86,"latestTime":"04-22 14:05:36 EDT","open":5.8324,"high":6.75,"low":5.72,"amount":805618.8012512,"amplitude":0.180385,"askPrice":6.69,"askSize":42,"bidPrice":6.56,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.976498,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1672290000000,"exchange":"NASDAQ","adjPreClose":5.71,"postHourTrading":{"tag":"盘后","latestPrice":5.71,"preClose":5.71,"latestTime":"19:57 EDT","volume":202,"amount":1226.63,"timestamp":1745279865261},"volumeRatio":2.133504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","floatShares":12564296,"roa":"-25.15%","roe":"-39.57%","lyrEps":-0.976498,"volumeRatio":2.133504,"shares":16724998,"dividePrice":0,"high":6.75,"amplitude":0.180385,"preClose":5.71,"low":5.72,"week52Low":4.65,"pbRate":"2.78","psRate":"30.92","week52High":10.24,"institutionHeld":0,"latestPrice":6.57,"committee":0.408451,"eps":-0.976498,"divideRate":0,"volume":126032,"delay":0,"ttmEps":-0.976498,"open":5.8324,"prevYearClose":5.73,"prevWeekClose":5.26,"prevMonthClose":6.47,"prevQuarterClose":6.47,"fiveDayClose":5.45,"twentyDayClose":6.65,"sixtyDayClose":5.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COYA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509275767","title":"Coya: Low-Dose IL-2 in AD patients resulted in reduced proinflammatory markers","url":"https://stock-news.laohu8.com/highlight/detail?id=2509275767","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509275767?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:30","pubTimestamp":1738848613,"startTime":"0","endTime":"0","summary":"Coya Therapeutics (COYA) announced encouraging blood biomarker data from an investigator-initiated, 21-week, double-blind, placebo-controlled, expl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coya-low-dose-il-2-in-ad-patients-resulted-in-reduced-proinflammatory-markers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coya-low-dose-il-2-in-ad-patients-resulted-in-reduced-proinflammatory-markers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2509273392","title":"Coya Therapeutics Inc - Ld Il-2 Well-Tolerated With No Serious Adverse Events Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2509273392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509273392?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:02","pubTimestamp":1738846974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nFWN3OX0UC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2509273330","title":"Coya Therapeutics Inc - Reports Significant Improvement in Inflammatory Markers in Alzheimer's Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2509273330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509273330?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:02","pubTimestamp":1738846974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nFWN3OX0UC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2509127339","title":"Coya Therapeutics Inc - Monthly Ld Il-2 Shows Significant Reduction in Ccl2 and Il-15, Increase in Il-4","url":"https://stock-news.laohu8.com/highlight/detail?id=2509127339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509127339?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:02","pubTimestamp":1738846974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nFWN3OX0UC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2509755202","title":"Coya Therapeutics Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer’s Disease Following Monthly Dosing with Low-Dose IL-2, Further Supporting Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2509755202","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509755202?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:00","pubTimestamp":1738846800,"startTime":"0","endTime":"0","summary":"Investigator-initiated data from Houston Methodist Hospital showed LD IL-2 reduced proinflammatory factors, both systemically and within the central nervous system, while demonstrating statistically significant improvement in beta amyloid 42 clearance with stabilization of cognitive decline over a five-month treatment period. Comprehensive data set will be presented and released throughout 2025 and in a peer reviewed publication. The statistically significant improvement in serum inflammatory markers corresponded with previously-reported findings from AD patients receiving monthly LD IL-2 compared to patients receiving biweekly LD IL-2 or placebo. Monthly LD IL-2 showed an increase in Aβ42 levels in cerebrospinal fluid , suggesting increased clearance of amyloid-β, stable levels of neurofilament light chain  in CSF, and statistically significant Treg expansion, all demonstrating targeted biological activity. In addition, patients receiving monthly LD IL-2 showed a 4.93-point improvemen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coya-therapeutics-reports-statistically-significant-130000484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PD","LU1169590202.USD","CSF","BK4139","COYA","LENZ","BK4023","LU1169589451.USD"],"gpt_icon":0},{"id":"2505427202","title":"Coya Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2505427202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505427202?lang=en_us&edition=fundamental","pubTime":"2025-01-21 23:06","pubTimestamp":1737471960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COYA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2025 10:06 ET (15:06 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","LENZ"],"gpt_icon":0},{"id":"2505220893","title":"Coya Therapeutics Announces Pipeline Expansion - Coya 303: Coya 301 in Combination With Glp-1 Receptor Agonist for the Treatment of Inflammatory Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2505220893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505220893?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:15","pubTimestamp":1737465300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUA8MM046:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2505022012","title":"EXCLUSIVE: Coya Therapeutics Expands Its Pipeline With Combo Therapy For Inflammatory Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2505022012","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505022012?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:00","pubTimestamp":1737464440,"startTime":"0","endTime":"0","summary":"On Tuesday, Coya Therapeutics, Inc.  announced the expansion of its investigational pipeline and advancement of COYA 303 for inflammatory diseases.COYA 303 is an investigational biologic combination of COYA 301 and a glucagon-like-peptide-1 receptor agonist  designed for subcutaneous administration.Also Read: EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases. \"COYA 303 is the most recent addition to Coya's investigational pipeline. We believe that while GLP-1 RAs may have monotherapy benefits in reducing inflammation, the unique anti-inflammatory signature of the combination of GLP-1 RA and COYA 301 is supportive of opportunities that may generate significant shareholder value for Coya and a potential strategic partner,\" stated CEO Arun Swaminathan.In December, Coya Therapeutics announced that five of eight patients enrolled in the investigator-initiated academic study of LD IL-2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-coya-therapeutics-expands-pipeline-130040435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0},{"id":"2492183931","title":"Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (Ld Il-2) + Ctla4-Ig Fusion Protein in Patients With Frontotemporal Dementia (Ftd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492183931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492183931?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:15","pubTimestamp":1734527700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nTUA7MZ0TY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2492185712","title":"Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492185712","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492185712?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:15","pubTimestamp":1734527700,"startTime":"0","endTime":"0","summary":"This open-label Phase 1 study measures safety, peripheral and central inflammation, effects on Treg cell populations, and FTD progression;Five of the 8 planned FTD subjects have been enrolled to date;Results of study will inform Coya’s randomized, double-blinded Phase 2 trial of COYA 302 in patients with FTD. Prior data presented by the investigators at the AD/PD 2024 Conference in March 2024 demonstrated that Treg suppressive function was significantly reduced in patients with FTD, compared to controls , demonstrating that Treg immunomodulatory function is negatively impacted in FTD and peripheral levels of inflammatory cytokines and chemokines are increased, supporting the critical role of the immune system in the pathophysiology of FTD. Treg dysfunction and increased levels of inflammatory cytokines and chemokines have been previously reported by Coya in other serious and progressive neurodegenerative diseases and support the multi-pathway combination approach of COYA 302 to target ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coya-therapeutics-provides-enrollment-investigator-131500871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4023","LD","LU1169590202.USD","COYA","BK4139","LU1169589451.USD","PD","LENZ"],"gpt_icon":0},{"id":"2488606167","title":"Coya Therapeutics initiated with a Buy at D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2488606167","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488606167?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:10","pubTimestamp":1733314232,"startTime":"0","endTime":"0","summary":"D. Boral Capital initiated coverage of Coya Therapeutics (COYA) with a Buy rating and $15 price target Coya believes that through exactly the right...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-initiated-with-a-buy-at-d-boral-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-initiated-with-a-buy-at-d-boral-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0},{"id":"2486808262","title":"Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2486808262","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486808262?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:15","pubTimestamp":1732540500,"startTime":"0","endTime":"0","summary":"HOUSTON, November 25, 2024----Coya Therapeutics, Inc.  , a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell  function, announces that Chief Executive Officer Arun Swaminathan, Ph.D. and Executive Chairman Howard Berman, Ph.D. will participate in the 7th Annual Evercore HealthCONx Conference being held on December 3 – 5, 2024 at the Loews Coral Gables Hotel in Coral Gables, FL.On Tuesday, December 3 at 12:55 PM ET, Drs. Swaminathan and Berman will participate in a fireside chat moderated by Evercore ISI’s Director of Biotechnology and Pharmaceuticals Michael DiFiore. Drs. Swaminathan and Berman will also be available for one-on-one meetings throughout the conference.An archived webcast of the presentation will be available for one year on the \"Events and Presentations\" tab of the Coya Therapeutics website.This press release contains \"forward-looking\" statements that are based on our management’s beliefs and assumptions and on information cu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coya-therapeutics-participate-fireside-chat-131500389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COYA","BK4139","LENZ"],"gpt_icon":1},{"id":"2485417409","title":"Coya Therapeutics files to sell 1.38M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2485417409","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485417409?lang=en_us&edition=fundamental","pubTime":"2024-11-21 06:25","pubTimestamp":1732141518,"startTime":"0","endTime":"0","summary":"17:20 EST Coya Therapeutics (COYA) files to sell 1.38M shares of common stock for holders Published first on TheFly – the ultimate source for real-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-files-to-sell-1-38m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-files-to-sell-1-38m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0},{"id":"2485174512","title":"BRIEF-Coya Therapeutics Inc Files For Resale Of Up To 1.4 Million Shares By The Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2485174512","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485174512?lang=en_us&edition=fundamental","pubTime":"2024-11-21 06:17","pubTimestamp":1732141065,"startTime":"0","endTime":"0","summary":"BRIEF-Coya Therapeutics Inc Files For Resale Of Up To 1.4 Million Shares By The Selling Stockholders - SEC FilingNov 20 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS INC FILES FOR RESALE ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nFWN3MR1BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2485174326","title":"Coya Therapeutics Inc Files for Resale of up to 1.4 Mln Shares by the Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2485174326","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485174326?lang=en_us&edition=fundamental","pubTime":"2024-11-21 06:17","pubTimestamp":1732141026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nFWN3MR1BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2484427899","title":"Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2484427899","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484427899?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:15","pubTimestamp":1732022100,"startTime":"0","endTime":"0","summary":"HOUSTON, November 19, 2024----Coya Therapeutics, Inc.  , a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to stockholders from Chief Executive Officer Dr. Arun Swaminathan.Given my recent transition to the role of CEO, I wanted to share my thoughts on Coya and our future and to express my gratitude to our founder and Executive Chair, Dr. Howard Berman, whose bold vision has instilled the \"innovation and get-it-done\" culture in Coya’s DNA. We have made tremendous strides in 2024, repeatedly executing on our promises. As I look to 2025, I am confident that our nimble and highly experienced team will continue to exceed expectations.FTD  Program: We expect to see topline results in 2H 2025 from the investigator-initiated, open-label study of Low Dose IL-2  + CTLA4-Ig in FTD. Study endpoints will measure safety, peripheral and central inflammation, FTD progression, and pharmacodynamic effects on Treg cell population","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/coya-therapeutics-ceo-dr-arun-131500544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","COYA","LENZ"],"gpt_icon":1},{"id":"2481360602","title":"Coya Therapeutics: Expects in Q1/Q2 2025 Coya 301/Glp-1 Combination Data Submission for Publication and Additional Intellectual Property Filings","url":"https://stock-news.laohu8.com/highlight/detail?id=2481360602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481360602?lang=en_us&edition=fundamental","pubTime":"2024-11-06 21:00","pubTimestamp":1730898003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nTUA7RHK3T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2481460614","title":"Press Release: Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481460614","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481460614?lang=en_us&edition=fundamental","pubTime":"2024-11-06 21:00","pubTimestamp":1730898000,"startTime":"0","endTime":"0","summary":"Coya Therapeutics, Inc.  , a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell  function, provides a corporate update and announces its financial results for the quarter ended September 30, 2024.-- Announced positive results from an investigator initiated double-blind. study of low-dose interleukin-2  in patients with mild to. moderate Alzheimer's Disease  at the Clinical Trials on Alzheimer's. -- Filed patents for COYA 301 in combination with Glucagon-Like Peptide-1. -- Promoted Arun Swaminathan, Ph.D. to Chief Executive Officer, effective. November 1, 2024, while Howard Berman has transitioned from CEO to. -- Announced anti-inflammatory effects of COYA 302 in the brain from a. -- Aligned with FDA on the non-clinical data needed to support the planned. randomized, double-blind, placebo-controlled, Phase 2b trial of COYA-302. -- A Phase 1 investigator-initiated trial  combining LD IL-2 + CTLA4-Ig. investigator-initiated trial  study in pati","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","PD","BK4023","CSF","LU1169589451.USD","LU1169590202.USD","COYA","BK4139"],"gpt_icon":0},{"id":"2481762786","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2481762786","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481762786?lang=en_us&edition=fundamental","pubTime":"2024-11-06 19:00","pubTimestamp":1730890800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BATRA","ATS","MSFT","CXDO","ECPG","AADI","ASPN","AMD","EHAB","LAW","NVDA","MU","QCOM","AEVA","ERAS","TSM","CXT","DK","EFC","ALNT","CHRD","BATRK","CURI","CLDX","PLUS","EBS","CERT","ABUS","COHR","ALB","ASH","EVTC","ACT","EHTH","CLBT","OBDC","BWMN","BHVN","COYA","ALTG","ASML","INTC","ASC","CYTK","AEE","APP","EVO","ACLS","BAK","AAPL","AMPY","AUDC","AMZN","BROS","BIP","ET","BKD","BIRD","CHT"],"gpt_icon":1},{"id":"2480000718","title":"Coya Therapeutics New CEO Arun Swaminathan Takes Helm","url":"https://stock-news.laohu8.com/highlight/detail?id=2480000718","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480000718?lang=en_us&edition=fundamental","pubTime":"2024-11-01 20:40","pubTimestamp":1730464812,"startTime":"0","endTime":"0","summary":"Coya Therapeutics (COYA) said Friday that Arun Swaminathan has begun his term as the company's chief executive officer.The company said in August that Swaminathan, who was most recently Coya's chief business officer, succeeds Howard Berman, who will continue as executive chair.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":54,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COYA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1743048000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COYA","date":"2025-04-21","current":-5.911884,"percent":0.565217,"low":-18.170827,"twenty":-10.3533,"median":-7.71646,"eighty":-3.641368,"high":-2.532969,"avg":-7.453244,"sd":3.90231,"marketCap":87973489},"quantilePoints":[{"date":"2022-12-30","current":-4.259584,"twenty":-5.088378,"median":-4.673981,"eighty":-4.199135,"marketCap":45862003},{"date":"2023-01-06","current":-4.198451,"twenty":-4.75686,"median":-4.211892,"eighty":-4.164199,"marketCap":45203803},{"date":"2023-01-13","current":-4.315322,"twenty":-4.421315,"median":-4.259584,"eighty":-4.180381,"marketCap":46462126},{"date":"2023-01-20","current":-4.288262,"twenty":-4.396143,"median":-4.253021,"eighty":-4.180381,"marketCap":46170776},{"date":"2023-01-27","current":-4.181765,"twenty":-4.394298,"median":-4.256303,"eighty":-4.180658,"marketCap":45024142},{"date":"2023-02-03","current":-3.675163,"twenty":-4.351211,"median":-4.234322,"eighty":-4.117451,"marketCap":39569675},{"date":"2023-02-10","current":-3.877804,"twenty":-4.30991,"median":-4.190108,"eighty":-3.84096,"marketCap":41751462},{"date":"2023-02-17","current":-3.850171,"twenty":-4.288262,"median":-4.180381,"eighty":-3.855698,"marketCap":41453946},{"date":"2023-02-24","current":-3.684374,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":39668848},{"date":"2023-03-03","current":-4.089655,"twenty":-4.270282,"median":-4.071233,"eighty":-3.770128,"marketCap":44032421},{"date":"2023-03-10","current":-4.23703,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":45619175},{"date":"2023-03-17","current":-3.905437,"twenty":-4.29377,"median":-4.180381,"eighty":-3.822538,"marketCap":42048978},{"date":"2023-03-24","current":-3.73964,"twenty":-4.288262,"median":-4.108461,"eighty":-3.73964,"marketCap":40263880},{"date":"2023-03-31","current":-3.218192,"twenty":-4.288262,"median":-4.048207,"eighty":-3.707402,"marketCap":39406041},{"date":"2023-04-06","current":-3.099387,"twenty":-4.273878,"median":-3.979124,"eighty":-3.684448,"marketCap":37951295},{"date":"2023-04-14","current":-3.233436,"twenty":-4.261724,"median":-3.905437,"eighty":-3.63832,"marketCap":39592701},{"date":"2023-04-21","current":-3.534032,"twenty":-4.256278,"median":-3.877804,"eighty":-3.512909,"marketCap":43273430},{"date":"2023-04-28","current":-3.753386,"twenty":-4.253993,"median":-3.850523,"eighty":-3.541339,"marketCap":45959367},{"date":"2023-05-05","current":-4.053981,"twenty":-4.248953,"median":-3.850876,"eighty":-3.590423,"marketCap":49640095},{"date":"2023-05-12","current":-3.858435,"twenty":-4.25448,"median":-3.877804,"eighty":-3.627267,"marketCap":51231762},{"date":"2023-05-19","current":-4.210564,"twenty":-4.257931,"median":-3.905437,"eighty":-3.63832,"marketCap":55907282},{"date":"2023-05-26","current":-3.109224,"twenty":-4.25448,"median":-3.877804,"eighty":-3.560217,"marketCap":41283847},{"date":"2023-06-02","current":-3.431385,"twenty":-4.251665,"median":-3.850876,"eighty":-3.429011,"marketCap":45561450},{"date":"2023-06-09","current":-3.611196,"twenty":-4.244399,"median":-3.84096,"eighty":-3.421013,"marketCap":47948950},{"date":"2023-06-16","current":-3.618688,"twenty":-4.23703,"median":-3.850171,"eighty":-3.424798,"marketCap":48048429},{"date":"2023-06-23","current":-3.566243,"twenty":-4.23703,"median":-3.830566,"eighty":-3.428417,"marketCap":47352075},{"date":"2023-06-30","current":-3.146685,"twenty":-4.23703,"median":-3.818461,"eighty":-3.418016,"marketCap":41781243},{"date":"2023-07-07","current":-3.071764,"twenty":-4.235405,"median":-3.785695,"eighty":-3.362458,"marketCap":40786451},{"date":"2023-07-14","current":-3.041795,"twenty":-4.228928,"median":-3.76675,"eighty":-3.288681,"marketCap":40388534},{"date":"2023-07-21","current":-2.981859,"twenty":-4.224887,"median":-3.746054,"eighty":-3.233436,"marketCap":39592701},{"date":"2023-07-28","current":-3.019319,"twenty":-4.216174,"median":-3.721218,"eighty":-3.218192,"marketCap":40090097},{"date":"2023-08-04","current":-2.876969,"twenty":-4.203296,"median":-3.712007,"eighty":-3.16841,"marketCap":38199993},{"date":"2023-08-11","current":-2.839996,"twenty":-4.188439,"median":-3.693585,"eighty":-3.145639,"marketCap":36807285},{"date":"2023-08-18","current":-2.54832,"twenty":-4.180935,"median":-3.684466,"eighty":-3.105289,"marketCap":33027077},{"date":"2023-08-25","current":-2.709509,"twenty":-4.180381,"median":-3.675163,"eighty":-3.078507,"marketCap":35116139},{"date":"2023-09-01","current":-2.709509,"twenty":-4.180381,"median":-3.63832,"eighty":-3.046291,"marketCap":35116139},{"date":"2023-09-08","current":-3.691995,"twenty":-4.169593,"median":-3.63832,"eighty":-3.044792,"marketCap":47849471},{"date":"2023-09-15","current":-3.546157,"twenty":-4.135431,"median":-3.63832,"eighty":-3.058278,"marketCap":45959367},{"date":"2023-09-21","current":-3.031887,"twenty":-4.1047,"median":-3.619293,"eighty":-3.053783,"marketCap":39294264},{"date":"2023-09-29","current":-3.162374,"twenty":-4.08252,"median":-3.599887,"eighty":-3.071764,"marketCap":40985409},{"date":"2023-10-06","current":-2.594374,"twenty":-4.053747,"median":-3.556227,"eighty":-3.033869,"marketCap":33623952},{"date":"2023-10-13","current":-3.745724,"twenty":-4.05097,"median":-3.54621,"eighty":-3.041795,"marketCap":48545825},{"date":"2023-10-20","current":-3.937616,"twenty":-4.036232,"median":-3.575206,"eighty":-3.043294,"marketCap":51032803},{"date":"2023-10-27","current":-3.645941,"twenty":-4.021495,"median":-3.590557,"eighty":-3.046291,"marketCap":47252596},{"date":"2023-11-03","current":-3.684319,"twenty":-3.985193,"median":-3.599887,"eighty":-3.062774,"marketCap":47749992},{"date":"2023-11-10","current":-3.870934,"twenty":-4.021495,"median":-3.619293,"eighty":-3.071764,"marketCap":47850465},{"date":"2023-11-17","current":-4.057134,"twenty":-4.055242,"median":-3.63832,"eighty":-3.071764,"marketCap":50152180},{"date":"2023-11-24","current":-4.259991,"twenty":-4.064747,"median":-3.645941,"eighty":-3.07577,"marketCap":52659789},{"date":"2023-12-01","current":-4.324905,"twenty":-4.105159,"median":-3.675163,"eighty":-3.082268,"marketCap":53462223},{"date":"2023-12-08","current":-5.631302,"twenty":-4.180381,"median":-3.684374,"eighty":-3.084048,"marketCap":69611225},{"date":"2023-12-15","current":-7.875233,"twenty":-4.205719,"median":-3.689056,"eighty":-3.088687,"marketCap":97349529},{"date":"2023-12-22","current":-7.933482,"twenty":-4.235947,"median":-3.693585,"eighty":-3.093672,"marketCap":98069570},{"date":"2023-12-29","current":-8.842163,"twenty":-4.23703,"median":-3.709704,"eighty":-3.09424,"marketCap":109302208},{"date":"2024-01-05","current":-7.793685,"twenty":-4.253993,"median":-3.715021,"eighty":-3.09424,"marketCap":96341472},{"date":"2024-01-12","current":-7.877698,"twenty":-4.259991,"median":-3.721218,"eighty":-3.097328,"marketCap":97379997},{"date":"2024-01-19","current":-6.724011,"twenty":-4.272114,"median":-3.742682,"eighty":-3.100019,"marketCap":83118725},{"date":"2024-01-26","current":-6.99204,"twenty":-4.300291,"median":-3.753386,"eighty":-3.10427,"marketCap":86431950},{"date":"2024-02-02","current":-7.213454,"twenty":-4.321125,"median":-3.76675,"eighty":-3.109224,"marketCap":89168961},{"date":"2024-02-09","current":-7.935965,"twenty":-4.359055,"median":-3.785695,"eighty":-3.121212,"marketCap":98100263},{"date":"2024-02-16","current":-8.91485,"twenty":-4.404211,"median":-3.812795,"eighty":-3.139255,"marketCap":110200736},{"date":"2024-02-23","current":-10.04523,"twenty":-4.438913,"median":-3.822509,"eighty":-3.140292,"marketCap":124173901},{"date":"2024-03-01","current":-10.476406,"twenty":-5.628056,"median":-3.830566,"eighty":-3.144593,"marketCap":129503871},{"date":"2024-03-08","current":-10.441446,"twenty":-5.900696,"median":-3.837832,"eighty":-3.146685,"marketCap":129071712},{"date":"2024-03-15","current":-11.653399,"twenty":-6.72168,"median":-3.850171,"eighty":-3.146685,"marketCap":144053250},{"date":"2024-03-22","current":-18.042053,"twenty":-6.870845,"median":-3.854655,"eighty":-3.146752,"marketCap":144116957},{"date":"2024-03-28","current":-17.568699,"twenty":-6.99204,"median":-3.858435,"eighty":-3.147022,"marketCap":140335887},{"date":"2024-04-05","current":-16.744948,"twenty":-7.213454,"median":-3.877804,"eighty":-3.154698,"marketCap":133755895},{"date":"2024-04-12","current":-16.708387,"twenty":-7.481482,"median":-3.895399,"eighty":-3.162374,"marketCap":133463852},{"date":"2024-04-19","current":-15.428751,"twenty":-7.933482,"median":-3.905437,"eighty":-3.168361,"marketCap":123242331},{"date":"2024-04-26","current":-15.41047,"twenty":-7.947618,"median":-3.91531,"eighty":-3.168442,"marketCap":123096309},{"date":"2024-05-03","current":-16.050288,"twenty":-8.108228,"median":-3.925864,"eighty":-3.184145,"marketCap":128207070},{"date":"2024-05-10","current":-15.465312,"twenty":-8.157379,"median":-3.945867,"eighty":-3.193076,"marketCap":123534375},{"date":"2024-05-17","current":-12.046492,"twenty":-8.434421,"median":-4.006757,"eighty":-3.19913,"marketCap":124118462},{"date":"2024-05-24","current":-12.027546,"twenty":-8.842163,"median":-4.037702,"eighty":-3.208428,"marketCap":123923260},{"date":"2024-05-31","current":-11.153807,"twenty":-9.523158,"median":-4.053396,"eighty":-3.216239,"marketCap":114920875},{"date":"2024-06-07","current":-10.311731,"twenty":-10.30363,"median":-4.063993,"eighty":-3.218192,"marketCap":106244729},{"date":"2024-06-14","current":-11.493592,"twenty":-10.481448,"median":-4.089655,"eighty":-3.221544,"marketCap":118421776},{"date":"2024-06-21","current":-9.425336,"twenty":-10.483969,"median":-4.100207,"eighty":-3.22689,"marketCap":97111945},{"date":"2024-06-28","current":-8.996912,"twenty":-10.491151,"median":-4.108461,"eighty":-3.230001,"marketCap":92697765},{"date":"2024-07-05","current":-8.819633,"twenty":-10.481448,"median":-4.153411,"eighty":-3.232684,"marketCap":90871208},{"date":"2024-07-12","current":-10.592423,"twenty":-10.481448,"median":-4.180381,"eighty":-3.233436,"marketCap":109136778},{"date":"2024-07-15","current":-11.065167,"twenty":-10.491151,"median":-4.180381,"eighty":-3.233436,"marketCap":114007596},{"date":"2024-08-02","current":-9.957173,"twenty":-10.489011,"median":-4.181073,"eighty":-3.233436,"marketCap":102591615},{"date":"2024-08-09","current":-9.277604,"twenty":-10.476406,"median":-4.210564,"eighty":-3.233436,"marketCap":95589814},{"date":"2024-08-16","current":-7.550677,"twenty":-10.441446,"median":-4.229827,"eighty":-3.251575,"marketCap":76258753},{"date":"2024-08-23","current":-9.374293,"twenty":-10.311731,"median":-4.23703,"eighty":-3.274051,"marketCap":94676535},{"date":"2024-08-30","current":-8.852829,"twenty":-10.301605,"median":-4.249631,"eighty":-3.28015,"marketCap":89409963},{"date":"2024-09-06","current":-9.133154,"twenty":-10.286069,"median":-4.257518,"eighty":-3.290318,"marketCap":92241126},{"date":"2024-09-13","current":-8.982442,"twenty":-10.167203,"median":-4.259991,"eighty":-3.294066,"marketCap":90718995},{"date":"2024-09-20","current":-9.374293,"twenty":-10.063875,"median":-4.267746,"eighty":-3.325565,"marketCap":94676535},{"date":"2024-09-27","current":-9.46472,"twenty":-10.033878,"median":-4.288262,"eighty":-3.333863,"marketCap":95589814},{"date":"2024-10-04","current":-10.301173,"twenty":-10.081747,"median":-4.299205,"eighty":-3.345975,"marketCap":104037640},{"date":"2024-10-11","current":-10.45942,"twenty":-10.301259,"median":-4.315322,"eighty":-3.366953,"marketCap":105635877},{"date":"2024-10-18","current":-12.388535,"twenty":-10.462817,"median":-4.33302,"eighty":-3.382641,"marketCap":125119151},{"date":"2024-10-25","current":-14.93557,"twenty":-10.558363,"median":-4.357362,"eighty":-3.391203,"marketCap":150843162},{"date":"2024-10-31","current":-10.029891,"twenty":-10.623264,"median":-4.367898,"eighty":-3.402403,"marketCap":101297804},{"date":"2024-11-08","current":-10.271752,"twenty":-10.614867,"median":-4.40398,"eighty":-3.415739,"marketCap":109897843},{"date":"2024-11-15","current":-9.688453,"twenty":-10.599507,"median":-4.432103,"eighty":-3.422453,"marketCap":103657107},{"date":"2024-11-22","current":-9.494429,"twenty":-10.566878,"median":-5.088378,"eighty":-3.426607,"marketCap":101581241},{"date":"2024-11-29","current":-10.181526,"twenty":-10.529794,"median":-5.623188,"eighty":-3.429604,"marketCap":108932515},{"date":"2024-12-06","current":-9.338271,"twenty":-10.495432,"median":-5.858502,"eighty":-3.46435,"marketCap":99910497},{"date":"2024-12-13","current":-9.088417,"twenty":-10.483969,"median":-5.907187,"eighty":-3.516795,"marketCap":97237306},{"date":"2024-12-20","current":-8.057772,"twenty":-10.469612,"median":-6.712358,"eighty":-3.52129,"marketCap":86210395},{"date":"2024-12-27","current":-8.541863,"twenty":-10.455825,"median":-6.793932,"eighty":-3.523838,"marketCap":91389702},{"date":"2025-01-03","current":-8.916643,"twenty":-10.441446,"median":-6.852199,"eighty":-3.534032,"marketCap":95399488},{"date":"2025-01-10","current":-9.478813,"twenty":-10.430887,"median":-6.957079,"eighty":-3.543732,"marketCap":101414166},{"date":"2025-01-17","current":-8.744869,"twenty":-10.348577,"median":-6.99204,"eighty":-3.546199,"marketCap":93561669},{"date":"2025-01-24","current":-9.119649,"twenty":-10.325731,"median":-7.13188,"eighty":-3.555389,"marketCap":97571455},{"date":"2025-01-31","current":-9.150881,"twenty":-10.318171,"median":-7.256788,"eighty":-3.564349,"marketCap":97905604},{"date":"2025-02-07","current":-10.931086,"twenty":-10.318171,"median":-7.341641,"eighty":-3.568008,"marketCap":116952087},{"date":"2025-02-14","current":-10.681233,"twenty":-10.383279,"median":-7.550677,"eighty":-3.569184,"marketCap":114278896},{"date":"2025-02-21","current":-9.634972,"twenty":-10.398268,"median":-7.746602,"eighty":-3.574001,"marketCap":103084910},{"date":"2025-02-28","current":-10.509459,"twenty":-10.398268,"median":-7.876466,"eighty":-3.588691,"marketCap":112441077},{"date":"2025-03-07","current":-9.822362,"twenty":-10.45223,"median":-7.935965,"eighty":-3.604411,"marketCap":105089803},{"date":"2025-03-14","current":-10.119063,"twenty":-10.461335,"median":-7.947618,"eighty":-3.614193,"marketCap":108264217},{"date":"2025-03-21","current":-7.264209,"twenty":-10.461335,"median":-7.947618,"eighty":-3.619172,"marketCap":108097143},{"date":"2025-03-28","current":-7.743894,"twenty":-10.45223,"median":-7.935965,"eighty":-3.621104,"marketCap":115235236},{"date":"2025-04-04","current":-6.855987,"twenty":-10.436166,"median":-7.877698,"eighty":-3.629076,"marketCap":102022487},{"date":"2025-04-11","current":-5.540987,"twenty":-10.398268,"median":-7.770143,"eighty":-3.63832,"marketCap":82454240},{"date":"2025-04-17","current":-5.866927,"twenty":-10.3533,"median":-7.730177,"eighty":-3.639844,"marketCap":87304489},{"date":"2025-04-21","current":-5.911884,"twenty":-10.3533,"median":-7.71646,"eighty":-3.641368,"marketCap":87973489}],"updateTime":1745342546308}}}